Comparison of Two Different Optical Biometric Systems

Sponsor
Democritus University of Thrace (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05411341
Collaborator
(none)
100
1
12
8.3

Study Details

Study Description

Brief Summary

Primary objective of this study is to evaluate and compare the measurements of two different optical biometrics systems in patients who will undergo cataract surgery or presbyopia surgery using intraocular lenses (IOL-PC).

Condition or Disease Intervention/Treatment Phase
  • Device: Argos (Alcon Laboratories, Inc.)
  • Device: IOLMaster 500 (Carl Zeiss Meditec AG)

Detailed Description

This is a prospective study including patients visiting the outpatient Ophthalmology clinic of the University General Hospital of Alexandroupolis, who suffer from diagnosed cataract or presbyopia and are going to undergo implantation of intraocular lenses surgery. The patients will be fully informed about the procedure and the purpose of the study and a written informed consent will be provided by all participants. They will then undergo an ocular biometry examination using two optical biometric systems, Argos (Alcon Laboratories, Inc.) and IOLMaster 500 (Carl Zeiss Meditec AG). IOL Master 500 (Carl Zeiss Meditec AG) is a non-invasive optical biometer that uses partial coherence interferometry (PCI) with a wavelength of 780 nm to measure the AL of the eye. Argos (Alcon Laboratories, Inc.) is a novel non-invasive optical biometer that uses swept source optical coherence tomography (SS-OCT) with a wavelength of 1050 nm. The measurements of the two systems that will be compared are the axial length, the keratometry values, the anterior chamber depth (ACD), the horizontal corneal diameter (white to white [WTW]) and the lens power in diopters (D).

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Assessment of Two Different Optical Biometric Systems, Based on Different Optical Technologies in Patients With Cataract or Presbyopia
Anticipated Study Start Date :
Jun 1, 2022
Anticipated Primary Completion Date :
May 1, 2023
Anticipated Study Completion Date :
Jun 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Study Group

100 patients with diagnosed cataract or presbyopia who will undergo implantation of intraocular lenses surgery

Device: Argos (Alcon Laboratories, Inc.)
An ocular biometry examination will be performed on the affected eyes using the Argos device.

Device: IOLMaster 500 (Carl Zeiss Meditec AG)
An ocular biometry examination will be performed on the affected eyes using the IOL Master 500 device.

Outcome Measures

Primary Outcome Measures

  1. Axial length [1 week]

    The measurement of the axial length of the affected eye using both devices

  2. Keratometry values [1 week]

    The measurement of keratometry values K1: flat meridian of the anterior corneal surface and K2: steep meridian of the anterior corneal surface of the affected eye using both devices.

  3. Lens power (D) [1 week]

    The power of the lens is calculated by each device as a function of biometric measurements

Secondary Outcome Measures

  1. Anterior chamber depth (ACD) [1 week]

    The measurement of the anterior chamber depth (ACD) of the affected eye using both devices.

  2. Horizontal corneal diameter (white to white [WTW]) [1 week]

    The measurement of the horizontal corneal diameter of the affected eye using both devices.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients with cataract and/or presbyopia who will undergo intraocular lens implantation.
Exclusion Criteria:
  • Dense cataract that does not allow measurements to be taken with an optical biometrics system.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Ophthalmology, University Hospital of Alexandroupolis Alexandroupolis Evros Greece 68100

Sponsors and Collaborators

  • Democritus University of Thrace

Investigators

  • Study Chair: Georgios Labiris, MD, PhD, Department of Ophthalmology, University Hospital of Alexandroupolis, Alexandroupolis, Greece

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Georgios Labiris, Professor (Associate) of Democritus University of Thrace, Democritus University of Thrace
ClinicalTrials.gov Identifier:
NCT05411341
Other Study ID Numbers:
  • ES9/Th3/05-05-2022
First Posted:
Jun 9, 2022
Last Update Posted:
Jun 9, 2022
Last Verified:
Jun 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Georgios Labiris, Professor (Associate) of Democritus University of Thrace, Democritus University of Thrace
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 9, 2022